UniProt ID | RRP1B_HUMAN | |
---|---|---|
UniProt AC | Q14684 | |
Protein Name | Ribosomal RNA processing protein 1 homolog B | |
Gene Name | RRP1B | |
Organism | Homo sapiens (Human). | |
Sequence Length | 758 | |
Subcellular Localization | Nucleus, nucleolus . Nucleus, nucleoplasm . Chromosome . Predominantly located in the nucleolus with a small amount found in the nucleoplasm (PubMed:20926688). Associates with the perichromatin region during metaphase and with cytoplasmic foci during | |
Protein Description | Positively regulates DNA damage-induced apoptosis by acting as a transcriptional coactivator of proapoptotic target genes of the transcriptional activator E2F1. [PubMed: 20040599 Likely to play a role in ribosome biogenesis by targeting serine/threonine protein phosphatase PP1 to the nucleolus] | |
Protein Sequence | MAPAMQPAEIQFAQRLASSEKGIRDRAVKKLRQYISVKTQRETGGFSQEELLKIWKGLFYCMWVQDEPLLQEELANTIAQLVHAVNNSAAQHLFIQTFWQTMNREWKGIDRLRLDKYYMLIRLVLRQSFEVLKRNGWEESRIKVFLDVLMKEVLCPESQSPNGVRFHFIDIYLDELSKVGGKELLADQNLKFIDPFCKIAAKTKDHTLVQTIARGVFEAIVDQSPFVPEETMEEQKTKVGDGDLSAEEIPENEVSLRRAVSKKKTALGKNHSRKDGLSDERGRDDCGTFEDTGPLLQFDYKAVADRLLEMTSRKNTPHFNRKRLSKLIKKFQDLSEGSSISQLSFAEDISADEDDQILSQGKHKKKGNKLLEKTNLEKEKGSRVFCVEEEDSESSLQKRRRKKKKKHHLQPENPGPGGAAPSLEQNRGREPEASGLKALKARVAEPGAEATSSTGEESGSEHPPAVPMHNKRKRPRKKSPRAHREMLESAVLPPEDMSQSGPSGSHPQGPRGSPTGGAQLLKRKRKLGVVPVNGSGLSTPAWPPLQQEGPPTGPAEGANSHTTLPQRRRLQKKKAGPGSLELCGLPSQKTASLKKRKKMRVMSNLVEHNGVLESEAGQPQALGSSGTCSSLKKQKLRAESDFVKFDTPFLPKPLFFRRAKSSTATHPPGPAVQLNKTPSSSKKVTFGLNRNMTAEFKKTDKSILVSPTGPSRVAFDPEQKPLHGVLKTPTSSPASSPLVAKKPLTTTPRRRPRAMDFF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Sulfoxidation | ---MAPAMQPAEIQF ---CCCCCCHHHHHH | 4.83 | 21406390 | |
21 | 2-Hydroxyisobutyrylation | QRLASSEKGIRDRAV HHHHHCCCCHHHHHH | 62.68 | - | |
21 | Acetylation | QRLASSEKGIRDRAV HHHHHCCCCHHHHHH | 62.68 | 25953088 | |
21 | Ubiquitination | QRLASSEKGIRDRAV HHHHHCCCCHHHHHH | 62.68 | 24816145 | |
38 | Acetylation | LRQYISVKTQRETGG HHHHHCCCCCHHCCC | 31.95 | 25953088 | |
47 | Phosphorylation | QRETGGFSQEELLKI CHHCCCCCHHHHHHH | 39.70 | 30266825 | |
116 | Acetylation | IDRLRLDKYYMLIRL CCHHHHHHHHHHHHH | 42.76 | 26051181 | |
128 | Phosphorylation | IRLVLRQSFEVLKRN HHHHHHHHHHHHHHC | 19.55 | 24719451 | |
151 | Acetylation | VFLDVLMKEVLCPES HHHHHHHHHHHCCCC | 40.27 | 26051181 | |
160 | Phosphorylation | VLCPESQSPNGVRFH HHCCCCCCCCCCEEE | 29.61 | 21815630 | |
164 (in isoform 2) | Ubiquitination | - | 8.20 | 21890473 | |
178 | Acetylation | IYLDELSKVGGKELL EEHHHHHHCCCCHHH | 58.48 | 26051181 | |
182 | Acetylation | ELSKVGGKELLADQN HHHHCCCCHHHCCCC | 38.98 | 27452117 | |
182 | Ubiquitination | ELSKVGGKELLADQN HHHHCCCCHHHCCCC | 38.98 | 21906983 | |
182 (in isoform 1) | Ubiquitination | - | 38.98 | 21890473 | |
191 | Acetylation | LLADQNLKFIDPFCK HHCCCCCCCCCCCHH | 48.07 | 26051181 | |
191 | Ubiquitination | LLADQNLKFIDPFCK HHCCCCCCCCCCCHH | 48.07 | 29967540 | |
197 | S-nitrosocysteine | LKFIDPFCKIAAKTK CCCCCCCHHHHHCCC | 3.66 | - | |
197 | S-nitrosylation | LKFIDPFCKIAAKTK CCCCCCCHHHHHCCC | 3.66 | 19483679 | |
198 | Acetylation | KFIDPFCKIAAKTKD CCCCCCHHHHHCCCC | 35.44 | 26051181 | |
198 | Ubiquitination | KFIDPFCKIAAKTKD CCCCCCHHHHHCCCC | 35.44 | 29967540 | |
204 | 2-Hydroxyisobutyrylation | CKIAAKTKDHTLVQT HHHHHCCCCCHHHHH | 46.97 | - | |
204 | Ubiquitination | CKIAAKTKDHTLVQT HHHHHCCCCCHHHHH | 46.97 | 29967540 | |
224 | Phosphorylation | FEAIVDQSPFVPEET HHHHHCCCCCCCHHH | 18.82 | 26074081 | |
231 | Phosphorylation | SPFVPEETMEEQKTK CCCCCHHHHHHHCCC | 28.37 | 23532336 | |
237 | Phosphorylation | ETMEEQKTKVGDGDL HHHHHHCCCCCCCCC | 30.56 | 22617229 | |
238 | Ubiquitination | TMEEQKTKVGDGDLS HHHHHCCCCCCCCCC | 51.78 | 29967540 | |
245 | Phosphorylation | KVGDGDLSAEEIPEN CCCCCCCCHHHCCCC | 38.07 | 19664994 | |
255 | Phosphorylation | EIPENEVSLRRAVSK HCCCCHHHHHHHHHH | 15.24 | 22167270 | |
261 | Phosphorylation | VSLRRAVSKKKTALG HHHHHHHHHHHCCCC | 37.46 | 26074081 | |
262 | Ubiquitination | SLRRAVSKKKTALGK HHHHHHHHHHCCCCC | 52.25 | 24816145 | |
265 | Phosphorylation | RAVSKKKTALGKNHS HHHHHHHCCCCCCCC | 35.67 | - | |
278 | Phosphorylation | HSRKDGLSDERGRDD CCCCCCCCCCCCCCC | 42.85 | 21815630 | |
286 | Glutathionylation | DERGRDDCGTFEDTG CCCCCCCCCCCCCCC | 6.92 | 22555962 | |
292 | Phosphorylation | DCGTFEDTGPLLQFD CCCCCCCCCCHHHHC | 33.24 | 29214152 | |
306 | Methylation | DYKAVADRLLEMTSR CHHHHHHHHHHHHHC | 31.28 | 115492929 | |
314 | Ubiquitination | LLEMTSRKNTPHFNR HHHHHHCCCCCCCCH | 66.01 | 29967540 | |
316 | Phosphorylation | EMTSRKNTPHFNRKR HHHHCCCCCCCCHHH | 22.60 | 28555341 | |
335 | Phosphorylation | IKKFQDLSEGSSISQ HHHHHHHCCCCCHHH | 48.47 | 20873877 | |
338 | Phosphorylation | FQDLSEGSSISQLSF HHHHCCCCCHHHHHH | 22.05 | 20873877 | |
339 | Phosphorylation | QDLSEGSSISQLSFA HHHCCCCCHHHHHHC | 36.80 | 20873877 | |
341 | Phosphorylation | LSEGSSISQLSFAED HCCCCCHHHHHHCCC | 27.32 | 29632367 | |
344 | Phosphorylation | GSSISQLSFAEDISA CCCHHHHHHCCCCCC | 18.12 | 30266825 | |
350 | Phosphorylation | LSFAEDISADEDDQI HHHCCCCCCCCCHHH | 41.82 | 30266825 | |
359 | Phosphorylation | DEDDQILSQGKHKKK CCCHHHHHCCCCHHH | 38.22 | 30266825 | |
369 | Acetylation | KHKKKGNKLLEKTNL CCHHHHCHHHHHCCC | 64.22 | 12440423 | |
373 | 2-Hydroxyisobutyrylation | KGNKLLEKTNLEKEK HHCHHHHHCCCCCCC | 42.56 | - | |
378 | 2-Hydroxyisobutyrylation | LEKTNLEKEKGSRVF HHHCCCCCCCCCCEE | 68.82 | - | |
386 | Carbamidation | EKGSRVFCVEEEDSE CCCCCEEEECCCCCH | 3.26 | 17322306 | |
386 | Glutathionylation | EKGSRVFCVEEEDSE CCCCCEEEECCCCCH | 3.26 | 22555962 | |
392 | Phosphorylation | FCVEEEDSESSLQKR EEECCCCCHHHHHHH | 42.53 | 29255136 | |
394 | Phosphorylation | VEEEDSESSLQKRRR ECCCCCHHHHHHHHH | 40.06 | 30266825 | |
395 | Phosphorylation | EEEDSESSLQKRRRK CCCCCHHHHHHHHHH | 30.67 | 23401153 | |
398 | Acetylation | DSESSLQKRRRKKKK CCHHHHHHHHHHHHH | 53.84 | 26051181 | |
422 | Phosphorylation | GPGGAAPSLEQNRGR CCCCCCCHHHHHCCC | 39.55 | 25159151 | |
434 | Phosphorylation | RGREPEASGLKALKA CCCCCCHHHHHHHHH | 42.89 | 18669648 | |
437 | Ubiquitination | EPEASGLKALKARVA CCCHHHHHHHHHHHC | 56.02 | 24816145 | |
451 | Phosphorylation | AEPGAEATSSTGEES CCCCCCCCCCCCCCC | 18.08 | 23401153 | |
452 | Phosphorylation | EPGAEATSSTGEESG CCCCCCCCCCCCCCC | 32.71 | 23401153 | |
453 | Phosphorylation | PGAEATSSTGEESGS CCCCCCCCCCCCCCC | 35.76 | 29255136 | |
454 | Phosphorylation | GAEATSSTGEESGSE CCCCCCCCCCCCCCC | 48.67 | 29255136 | |
458 | Phosphorylation | TSSTGEESGSEHPPA CCCCCCCCCCCCCCC | 43.23 | 29255136 | |
460 | Phosphorylation | STGEESGSEHPPAVP CCCCCCCCCCCCCCC | 41.85 | 29255136 | |
471 | Acetylation | PAVPMHNKRKRPRKK CCCCCCCCCCCCCCC | 44.62 | 26051181 | |
479 | Phosphorylation | RKRPRKKSPRAHREM CCCCCCCCHHHHHHH | 23.74 | 26074081 | |
489 | Phosphorylation | AHREMLESAVLPPED HHHHHHHHHCCCHHH | 21.51 | 26074081 | |
498 | Phosphorylation | VLPPEDMSQSGPSGS CCCHHHHHCCCCCCC | 33.25 | 22199227 | |
500 | Phosphorylation | PPEDMSQSGPSGSHP CHHHHHCCCCCCCCC | 45.42 | 26074081 | |
503 | Phosphorylation | DMSQSGPSGSHPQGP HHHCCCCCCCCCCCC | 57.35 | 27174698 | |
505 | Phosphorylation | SQSGPSGSHPQGPRG HCCCCCCCCCCCCCC | 36.01 | 26074081 | |
513 | Phosphorylation | HPQGPRGSPTGGAQL CCCCCCCCCCCHHHH | 22.14 | 29255136 | |
515 | Phosphorylation | QGPRGSPTGGAQLLK CCCCCCCCCHHHHHH | 50.36 | 30266825 | |
522 | Acetylation | TGGAQLLKRKRKLGV CCHHHHHHCCCCCCC | 65.55 | 25953088 | |
522 | Methylation | TGGAQLLKRKRKLGV CCHHHHHHCCCCCCC | 65.55 | 115977411 | |
522 | Ubiquitination | TGGAQLLKRKRKLGV CCHHHHHHCCCCCCC | 65.55 | 24816145 | |
535 | Phosphorylation | GVVPVNGSGLSTPAW CCEECCCCCCCCCCC | 31.21 | 22210691 | |
538 | Phosphorylation | PVNGSGLSTPAWPPL ECCCCCCCCCCCCCC | 35.55 | 22210691 | |
539 | Phosphorylation | VNGSGLSTPAWPPLQ CCCCCCCCCCCCCCC | 23.28 | - | |
579 | Phosphorylation | KKKAGPGSLELCGLP HCCCCCCCCHHCCCC | 23.08 | 25159151 | |
583 | Glutathionylation | GPGSLELCGLPSQKT CCCCCHHCCCCCCCC | 3.72 | 22555962 | |
587 | Phosphorylation | LELCGLPSQKTASLK CHHCCCCCCCCCCCH | 49.72 | 24667141 | |
592 | Phosphorylation | LPSQKTASLKKRKKM CCCCCCCCCHHHHHH | 46.05 | 26074081 | |
624 | Phosphorylation | GQPQALGSSGTCSSL CCCCHHCCCCCCHHH | 26.84 | 25159151 | |
625 | Phosphorylation | QPQALGSSGTCSSLK CCCHHCCCCCCHHHH | 36.00 | 25159151 | |
627 | Phosphorylation | QALGSSGTCSSLKKQ CHHCCCCCCHHHHHH | 15.91 | 25159151 | |
629 | Phosphorylation | LGSSGTCSSLKKQKL HCCCCCCHHHHHHHH | 38.24 | 25159151 | |
630 | Phosphorylation | GSSGTCSSLKKQKLR CCCCCCHHHHHHHHH | 46.48 | 25159151 | |
632 | Acetylation | SGTCSSLKKQKLRAE CCCCHHHHHHHHHHC | 55.92 | 25953088 | |
634 (in isoform 2) | Ubiquitination | - | 48.72 | 21890473 | |
640 | Phosphorylation | KQKLRAESDFVKFDT HHHHHHCCCCCCCCC | 35.05 | 25159151 | |
647 | Phosphorylation | SDFVKFDTPFLPKPL CCCCCCCCCCCCCCC | 21.05 | 22199227 | |
652 | Acetylation | FDTPFLPKPLFFRRA CCCCCCCCCCCEEEC | 57.40 | 19608861 | |
652 | Ubiquitination | FDTPFLPKPLFFRRA CCCCCCCCCCCEEEC | 57.40 | 22817900 | |
652 (in isoform 1) | Ubiquitination | - | 57.40 | 21890473 | |
661 | Phosphorylation | LFFRRAKSSTATHPP CCEEECCCCCCCCCC | 31.75 | 28450419 | |
662 | Phosphorylation | FFRRAKSSTATHPPG CEEECCCCCCCCCCC | 22.73 | 30576142 | |
663 | Phosphorylation | FRRAKSSTATHPPGP EEECCCCCCCCCCCC | 42.54 | 28450419 | |
665 | Phosphorylation | RAKSSTATHPPGPAV ECCCCCCCCCCCCCE | 34.70 | 28450419 | |
676 | Acetylation | GPAVQLNKTPSSSKK CCCEECCCCCCCCCC | 71.10 | 26051181 | |
677 | Phosphorylation | PAVQLNKTPSSSKKV CCEECCCCCCCCCCE | 27.59 | 23927012 | |
679 | Phosphorylation | VQLNKTPSSSKKVTF EECCCCCCCCCCEEE | 53.10 | 23927012 | |
680 | Phosphorylation | QLNKTPSSSKKVTFG ECCCCCCCCCCEEEE | 47.59 | 25159151 | |
681 | Phosphorylation | LNKTPSSSKKVTFGL CCCCCCCCCCEEEEE | 40.61 | 23927012 | |
693 | Phosphorylation | FGLNRNMTAEFKKTD EEECCCCCEEEECCC | 26.95 | 28555341 | |
699 | Phosphorylation | MTAEFKKTDKSILVS CCEEEECCCCCEEEC | 49.61 | 24732914 | |
701 | Ubiquitination | AEFKKTDKSILVSPT EEEECCCCCEEECCC | 44.63 | 24816145 | |
702 | Phosphorylation | EFKKTDKSILVSPTG EEECCCCCEEECCCC | 24.78 | 30266825 | |
706 | Phosphorylation | TDKSILVSPTGPSRV CCCCEEECCCCCCCC | 17.19 | 19664994 | |
708 | Phosphorylation | KSILVSPTGPSRVAF CCEEECCCCCCCCEE | 54.97 | 30266825 | |
711 | Phosphorylation | LVSPTGPSRVAFDPE EECCCCCCCCEECCC | 40.51 | 30183078 | |
712 | Citrullination | VSPTGPSRVAFDPEQ ECCCCCCCCEECCCC | 27.24 | - | |
712 | Citrullination | VSPTGPSRVAFDPEQ ECCCCCCCCEECCCC | 27.24 | - | |
720 | Acetylation | VAFDPEQKPLHGVLK CEECCCCCCCCCCCC | 48.13 | 23749302 | |
727 | Methylation | KPLHGVLKTPTSSPA CCCCCCCCCCCCCCC | 50.48 | 115977419 | |
728 | Phosphorylation | PLHGVLKTPTSSPAS CCCCCCCCCCCCCCC | 27.86 | 29255136 | |
730 | Phosphorylation | HGVLKTPTSSPASSP CCCCCCCCCCCCCCC | 47.25 | 29255136 | |
731 | O-linked_Glycosylation | GVLKTPTSSPASSPL CCCCCCCCCCCCCCC | 35.21 | 19664995 | |
731 | O-linked_Glycosylation | GVLKTPTSSPASSPL CCCCCCCCCCCCCCC | 35.21 | 19664995 | |
731 | Phosphorylation | GVLKTPTSSPASSPL CCCCCCCCCCCCCCC | 35.21 | 29255136 | |
732 | Phosphorylation | VLKTPTSSPASSPLV CCCCCCCCCCCCCCC | 27.28 | 19664994 | |
735 | Phosphorylation | TPTSSPASSPLVAKK CCCCCCCCCCCCCCC | 35.55 | 29255136 | |
736 | Phosphorylation | PTSSPASSPLVAKKP CCCCCCCCCCCCCCC | 25.10 | 29255136 | |
741 | Acetylation | ASSPLVAKKPLTTTP CCCCCCCCCCCCCCC | 47.66 | 25953088 | |
745 | Phosphorylation | LVAKKPLTTTPRRRP CCCCCCCCCCCCCCC | 36.83 | 20068231 | |
746 | Phosphorylation | VAKKPLTTTPRRRPR CCCCCCCCCCCCCCC | 42.35 | 30576142 | |
747 | Phosphorylation | AKKPLTTTPRRRPRA CCCCCCCCCCCCCCC | 15.01 | 26055452 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RRP1B_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RRP1B_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RRP1B_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
LC7L3_HUMAN | LUC7L3 | physical | 19710015 | |
YBOX3_HUMAN | YBX3 | physical | 19710015 | |
CUBN_HUMAN | CUBN | physical | 19710015 | |
DDX21_HUMAN | DDX21 | physical | 19710015 | |
H1X_HUMAN | H1FX | physical | 19710015 | |
ROA1_HUMAN | HNRNPA1 | physical | 19710015 | |
ILF3_HUMAN | ILF3 | physical | 19710015 | |
LARP1_HUMAN | LARP1 | physical | 19710015 | |
LC7L2_HUMAN | LUC7L2 | physical | 19710015 | |
NUCL_HUMAN | NCL | physical | 19710015 | |
NPM_HUMAN | NPM1 | physical | 19710015 | |
PARP1_HUMAN | PARP1 | physical | 19710015 | |
PP1A_HUMAN | PPP1CA | physical | 19710015 | |
PRP4B_HUMAN | PRPF4B | physical | 19710015 | |
RL10A_HUMAN | RPL10A | physical | 19710015 | |
RL4_HUMAN | RPL4 | physical | 19710015 | |
RL5_HUMAN | RPL5 | physical | 19710015 | |
RLA0_HUMAN | RPLP0 | physical | 19710015 | |
RL1D1_HUMAN | RSL1D1 | physical | 19710015 | |
SDF2L_HUMAN | SDF2L1 | physical | 19710015 | |
SRSF1_HUMAN | SRSF1 | physical | 19710015 | |
SRSF6_HUMAN | SRSF6 | physical | 19710015 | |
S22AB_HUMAN | SLC22A11 | physical | 19710015 | |
THOC4_HUMAN | ALYREF | physical | 19710015 | |
TOP1_HUMAN | TOP1 | physical | 19710015 | |
PP1R7_HUMAN | PPP1R7 | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-652, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245; SER-350; SER-732AND SER-735, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245; SER-392; THR-451;SER-453; THR-454; SER-458; SER-460; SER-513; SER-706; THR-728;SER-731; SER-732 AND SER-736, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245; SER-350; SER-392;SER-394; SER-395; SER-452; SER-453; SER-458; SER-702; SER-706; SER-732AND SER-736, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245 AND SER-513, ANDMASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245; SER-513; THR-515;SER-706; SER-711; SER-732 AND SER-736, AND MASS SPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-513 AND THR-747, ANDMASS SPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-732, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-392; SER-513 ANDSER-706, AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245, AND MASSSPECTROMETRY. |